SURREY AND BORDERS PARTNERSHIP NHS FOUNDATION TRUST

Their core work

Surrey and Borders Partnership NHS Foundation Trust operates under the commercial brand NHS Commercial Solutions, functioning as a specialist public procurement body within the UK's National Health Service. Their H2020 work sits at a specific niche: they help European public health authorities buy innovative technologies more effectively, using procurement methods like Pre-Commercial Procurement (PCP) and Public Procurement of Innovation (PPI) to pull market-ready solutions into healthcare systems. In practice, this means they design and run procurement frameworks that let health bodies acquire things like smart ambulance systems or rapid diagnostics without defaulting to lowest-cost vendors. They are buyers who understand EU procurement law, clinical value, and cross-border coordination — not a research lab, but a critical link between research outputs and health system adoption.

What they specialise in

How they've shifted over time

In 2015, their H2020 focus was narrowly digital and operationally specific — procuring smart ambulance systems through a European platform of public buyers. By 2019-2020, the scope had broadened considerably: EURIPHI brought in health-system-wide concepts like integrated care, value-based contracting (MEAT), cross-border procurement, and infectious disease diagnostics. The shift is from a single-technology procurement exercise toward building repeatable, cross-national frameworks for health innovation procurement across multiple clinical domains.

They are moving from coordinating single-use procurement exercises toward contributing specialist public-buyer expertise to large European procurement consortia covering multiple health technology domains.

How they like to work

They have played both the lead (coordinator on SAEPP) and a supporting partner role (participant on EURIPHI), suggesting flexibility depending on whether the procurement challenge matches their specific operational expertise. Despite only two projects, they have connected with 43 distinct partners — indicating they plug into wide, multi-stakeholder European procurement networks rather than working in closed, repeat-partner arrangements. Expect them to bring NHS buyer authority and real-world procurement process knowledge rather than technical R&D capacity.

43 unique consortium partners across 12 countries from just two projects — an unusually broad network for a small project portfolio, reflecting the large multi-country consortia typical of EU procurement innovation actions. Their network skews toward other public health authorities, procurers, and health ministries rather than universities or industry labs.

What sets them apart

Very few NHS bodies have appeared as H2020 coordinators, making this organisation a rare example of a UK public health authority with demonstrated experience leading European procurement innovation projects. Their NHS Commercial Solutions identity means they bring institutional procurement authority that academic or consultancy partners cannot — they are an actual public buyer, which gives PPI/PCP consortia credibility with the European Commission and legitimacy in procurement law contexts. For any consortium building a health technology procurement project, they offer a combination of clinical operational context and public contracting experience that is hard to replicate from outside the NHS.

Highlights from their portfolio

• SAEPP
  Rare example of an NHS trust acting as H2020 project coordinator, leading a pan-European platform for procuring smart ambulance technology — a digital-health crossover role that most NHS bodies never occupy.
• EURIPHI
  Part of a European-wide consortium tackling health innovation procurement across multiple domains — integrated care, rapid diagnostics, infectious disease — demonstrating the organisation's evolution from single-technology to system-level procurement frameworks.